retatrutide weight loss results clinical trials Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial retatrutide clinical trial stage New

It can mitigate inflammation associated with inflammatory bowel diseases (IBD) like ulcerative colitis

This treatment combines two technologies: Ultrasound Cavitation : Uses sound waves to break down fat cells, which are then naturally eliminated by your bodys lymphatic system

Oxygen sensing and metabolic homeostasis

Although basic research has shown that targeting these pathological processes can help alleviate clinical manifestationssuch as reducing pancreatic edema, attenuating inflammation, and limiting organ dysfunctionmost of these strategies remain limited to cellular or animal models and have not yet undergone large-scale clinical validation